title: [Ganglioside GD3 enhances the anti-tumor effect of doxorubicin on hepatoma cells].
authors.affiliation: Department of Gastroenterology, First Affiliated Hospital, Wenzhou Medical College, Wenzhou 325000, China. wang730221@vip.sina.com
authors.forename: Jian-hong
authors.initials: JH
authors.lastname: Wang
authors.forename: Zhi-ming
authors.initials: ZM
authors.lastname: Huang
authors.forename: Jian-shen
authors.initials: JS
authors.lastname: Wu
authors.forename: Xiang-rong
authors.initials: XR
authors.lastname: Chen
authors.forename: Shu-qing
authors.initials: SQ
authors.lastname: Jin
authors.forename: Qing-ke
authors.initials: QK
authors.lastname: Huang
authors.forename: Dan
authors.initials: D
authors.lastname: Wang
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D017209:Apoptosis; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000494:pharmacology*; D005732:Gangliosides; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism
chemical_list: D000903:Antibiotics, Antineoplastic; D005732:Gangliosides; D016328:NF-kappa B; C026226:ganglioside, GD3; D004317:Doxorubicin